COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,725 Articles (22,913 medRxiv, 8,812 bioRxiv)

Most recent first Previous |  Page 743: Articles 7421-7430  | Next

Safety and biodistribution of NanoligomersTM targeting SARS-CoV-2 genome for treatment of COVID-19
McCollum, C. R., Courtney, C. M., O'Connor, N. J., Aunins, T. R., Jordan, T. X., Rogers, K., Brindley, S., Brown, J. M., Nagpal, P., Chatterjee, A.
10.1101/2022.07.19.500688 — Posted: 2022-07-20
Evasion of neutralizing antibodies by Omicron sublineage BA.2.75
Sheward, D. J., Kim, C., Fischbach, J., Muschiol, S., Ehling, R. A., Björkström, N. K., Karlsson Hedestam, G. B., Reddy, S. T., Albert, J., Peacock, T. P., Murrell, B.
10.1101/2022.07.19.500716 — Posted: 2022-07-20
Regulation of mRNA transcripts, protein isoforms, glycosylation and spatial localization of ACE2 and other SARS-CoV-2-associated molecules in human airway epithelium upon viral infection and type 2 inflammation
Stocker, N., Radzikowska, U., Wawrzyniak, P., Tan, G., Huang, M., Ding, M., Akdis, C., Sokolowska, M.
10.1101/2022.07.19.500631 — Posted: 2022-07-20
Vaccination shapes evolutionary trajectories of SARS-CoV-2
Meijers, M., Ruchnewitz, D., Luksza, M., Lässig, M.
10.1101/2022.07.19.500637 — Posted: 2022-07-20
Persistence of SARS-CoV-2 neutralizing antibodies longer than 13 months in naturally-infected, captive white-tailed deer (Odocoileus virginianus), Texas
Hamer, S. A., Nunez, C. M., Roundy, C., Tang, W., Thomas, L. F., Richison, J. J., Benn, J., Auckland, L., Hensley, T., Cook, W. E., Pauvolid-Correa, A., Hamer, G.
10.1101/2022.07.19.500662 — Posted: 2022-07-19
Neutralizing antibody evasion and receptor binding features of SARS-CoV-2 Omicron BA.2.75
Cao, Y., Yu, Y., Song, W., Jian, F., Yisimayi, A., Yue, C., Feng, R., Wang, P., Yu, L., Zhang, N., Wang, J., Xiao, T., An, R., Wang, Y., Wang, J., Liu, L., Yang, S., Niu, X., Gu, Q., Shao, F., Hao, X., Jin, R., Wang, X., Wang, Y., Xie, X. S.
10.1101/2022.07.18.500332 — Posted: 2022-07-19
The First Geographic Identification by Country of Sustainable Mutations of SARS-COV-2 Sequence Samples: Worldwide Natural Selection Trends
Mahmanzar, m., Houseini, S. T., Rahimian, K., Mikaeili Namini, A., Gholamzad, A., Tokhanbigli, S., Mollapour Sisakht, M., Farhadi, A., Lee Kuehu, D., Deng, Y.
10.1101/2022.07.18.500565 — Posted: 2022-07-19
Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant
Camacho, J., Gimenez, E., Albert, E., Zulaica, J., Alvarez-Rodriguez, B., Torres, I., Rusu, L., Burgos, J., Peiro, S., Vanaclocha, H., Limon, R., Alcaraz, M. J., Paya, J., Domingo, J., Comas, I., Gonzalez-Candelas, F., Geller, R., Navarro, D.
10.1101/2022.07.19.22277747 — Posted: 2022-07-19
Determinants of healthcare employee preference to continue teleworking after the COVID-19 pandemic: a cross-sectional study using hierarchical regression
Jones, A. M., Fan, J., Thomas-Olson, L., Zhang, W., McLeod, C. B.
10.1101/2022.07.18.22277694 — Posted: 2022-07-19
Discovering host protein interactions specific for SARS-CoV-2 RNA genome
Giambruno, R., Zacco, E., Ugolini, C., Vandelli, A., Mulroney, L., D'Onghia, M., Criscuolo, E., Castelli, M., Clementi, N., Clementi, M., Mancini, N., Bonaldi, T., Gustincich, S., Leonardi, T., Tartaglia, G. G., Nicassio, F.
10.1101/2022.07.18.499583 — Posted: 2022-07-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).